Conversely, Faria et al. (Mayara Chaves Faria et al., 2014a, 2014b) discovered that AD patients had higher serum BDNF levels than healthy controls as a compensatory mechanism to limit further neurodegeneration. The gene discussed is BDNF; the disease is Alzheimer disease.